These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2434058)

  • 1. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy.
    Lotti M; Moretto A; Zoppellari R; Dainese R; Rizzuto N; Barusco G
    Arch Toxicol; 1986 Oct; 59(3):176-9. PubMed ID: 2434058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances.
    Johnson MK; Glynn P
    Toxicol Lett; 1995 Dec; 82-83():459-63. PubMed ID: 8597094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpyrifos-induced delayed polyneuropathy.
    Capodicasa E; Scapellato ML; Moretto A; Caroldi S; Lotti M
    Arch Toxicol; 1991; 65(2):150-5. PubMed ID: 1711837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTE soluble isoforms: new perspectives for targets of neuropathy inducers and promoters.
    Vilanova E; Escudero MA; Barril J
    Chem Biol Interact; 1999 May; 119-120():525-40. PubMed ID: 10421492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organophosphate polyneuropathy: pathogenesis and prevention.
    Lotti M; Becker CE; Aminoff MJ
    Neurology; 1984 May; 34(5):658-62. PubMed ID: 6324035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors.
    Lotti M; Moretto A
    Chem Biol Interact; 1999 May; 119-120():519-24. PubMed ID: 10421491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells.
    Ehrich M; Correll L; Veronesi B
    Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: application to assessment of neuropathic risk.
    Richardson RJ; Moore TB; Kayyali US; Fowke JH; Randall JC
    Fundam Appl Toxicol; 1993 Apr; 20(3):273-9. PubMed ID: 7684990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible inhibition can profoundly mislead studies on progressive inhibition of enzymes: the interaction of paraoxon with soluble neuropathy target esterase.
    Barril J; Vilanova E
    Chem Biol Interact; 1997 Dec; 108(1-2):19-25. PubMed ID: 9463518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte esterases and hydroxylases in neurotoxicology.
    Fournier L; Musard D; Lecorsier A
    Vet Hum Toxicol; 1996 Jun; 38(3):190-5. PubMed ID: 8727218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organophosphate polyneuropathy in chicks.
    Peraica M; Capodicasa E; Moretto A; Lotti M
    Biochem Pharmacol; 1993 Jan; 45(1):131-5. PubMed ID: 8381002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organophosphate neuropathy due to methamidophos: biochemical and neurophysiological markers.
    McConnell R; Delgado-Téllez E; Cuadra R; Tórres E; Keifer M; Almendárez J; Miranda J; El-Fawal HA; Wolff M; Simpson D; Lundberg I
    Arch Toxicol; 1999 Aug; 73(6):296-300. PubMed ID: 10447555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
    Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delayed polyneuropathy induced by organophosphorus esters].
    Lotti M
    Riv Neurobiol; 1982; 28(3-4):498-506. PubMed ID: 6195725
    [No Abstract]   [Full Text] [Related]  

  • 15. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride.
    Lotti M; Caroldi S; Capodicasa E; Moretto A
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):234-41. PubMed ID: 2017753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological monitoring for organophosphate-induced delayed polyneuropathy.
    Lotti M
    Toxicol Lett; 1986 Oct; 33(1-3):167-72. PubMed ID: 3535171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and clinical tests of the delayed neuropathic potential of some O-alkyl O-dichlorophenyl phosphoramidate analogues of methamidophos (O,S-dimethyl phosphorothioamidate).
    Johnson MK; Vilanova E; Read DJ
    Toxicology; 1989 Jan; 54(1):89-100. PubMed ID: 2536970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks.
    Moretto A; Capodicasa E; Peraica M; Lotti M
    Biochem Pharmacol; 1991 May; 41(10):1497-504. PubMed ID: 2018554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters.
    Johnson MK
    Chem Biol Interact; 1993 Jun; 87(1-3):339-46. PubMed ID: 8343991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
    Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
    J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.